Australian MP George Christensen has hit out at the Labor Party after its deputy opposition leader called for him to be punished for his views on mandatory COVID-19 vaccinations. “Labor are now calling for my removal from parliament for daring to challenge the pandemic orthodoxy,” Christensen wrote on Facebook on Thursday. “Think about it: they…
Australian MP Says Opposition Want Him Silenced for Challenging ‘Pandemic Orthodoxy’
Lawmakers Urge FDA to Explain ‘Unusual Decision’ to Clear Booster Shots for Children
Twenty-five members of Congress are asking U.S. drug regulators to explain why they cleared COVID-19 vaccine booster shots for 12- to 15-year-olds without consulting a panel of expert advisers. The population is at little risk of severe illness or death from COVID-19 but the Food and Drug Administration (FDA) earlier this month authorized a booster of…
Fourth Shot of COVID-19 Vaccine Can’t Prevent Omicron Infection: Israeli Study
A second booster shot of Pfizer’s COVID-19 vaccine induced antibodies but likely not at a level high enough to protect recipients against infection from the Omicron virus variant, Israeli researchers said Monday. Sheba Medical Center has been studying 150 health care workers who received a second booster, or a fourth shot. “Two weeks after administering…
Health Canada Approves Pfizer Antiviral
OTTAWA—Health Canada has approved Pfizer’s antiviral treatment for COVID-19. The authorization posted to the Health Canada website this morning says the treatment is greenlighted for adult patients with mild or moderate COVID-19 who are also at high risk of becoming more seriously ill. Health Canada did not authorize it for use on teenagers. It is…
Pfizer CEO Predicts ‘Return to Normal’ by Spring But Expects COVID-19 to Circulate for Years
Pfizer CEO Albert Bourla told French news outlets in recent interviews that, while he expects COVID-19 to continue to circulate for many years, he thinks future waves won’t be beset by major restrictions while predicting life will return to “normal” around springtime. Bourla told French news outlet Le Figaro in an interview published Jan. 16…
Pfizer Says It Applied for Japan Government’s Approval for Oral COVID-19 Drug
TOKYO—U.S. drugmaker Pfizer Inc. said on Friday it has applied for Japanese government approval for its oral COVID-19 treatment. The application is based on global Phase II/III trials that Japan was part of, Pfizer said in a statement. With COVID-19 cases surging again, Japan is betting heavily on oral treatments to keep serious infections and…
Pfizer: Updated COVID-19 Vaccine Data for Children Under 5 Expected by April
Pfizer has amended its COVID-19 vaccine trial for younger children and expects results in several months, a researcher said Wednesday. The study has been adjusted from two doses to three doses in light of the growing body of evidence showing the primary regimen’s effects wane as time goes on from vaccination, Dr. Alejandra Gurtman, part of…
CDC Recommends Children 12 to 17 Get a COVID-19 Booster Shot
The Centers for Disease Control and Prevention (CDC) on Wednesday said children from 12 to 17 years old should get a COVID-19 vaccine booster, despite scant effectiveness data and concerns about post-vaccination heart inflammation. The agency endorsed recommendations from its vaccine advisory panel, which voted 13–1 to advise the CDC to say children in the age group…
Shares in COVID-19 Vaccine Developer Valneva Extend Fall
PARIS—Shares in biotech company Valneva fell again on Wednesday, declining for the seventh day in a row due to a growing belief amongst investors that the COVID-19 Omicron variant might lessen the need for mass vaccination. At 0945 GMT, Valneva shares were down 3 percent at 17.10 euros, meaning the stock has now lost close…
Pfizer and BioNTech Announce Collaboration on mRNA Shingles Vaccines
Pfizer and its German partner on Tuesday announced they will work together on a shingles vaccine that utilizes messenger RNA technology. Pfizer and BioNTech created one of the most-used COVID-19 vaccines in the world by using the technology, which had never been cleared for use in any countries before the pandemic. Under a new agreement,…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`